An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease

Study Purpose

This study seeks to evaluate the safety and efficacy of brazikumab versus placebo (Stage I) and versus an active comparator (Stage 2) in participants with moderately to severely active CD and will include assessments of clinical response as demonstrated by improvement of symptoms and colonic mucosal appearance as observed on endoscopy

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

No
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Interventional
Eligible Ages 18 Years - 80 Years
Gender All
More Inclusion & Exclusion Criteria

Inclusion and Exclusion Criteria are the same for both Stage 1 and Stage 2; however, participants enrolled in Stage 1 will not be permitted to enroll in Stage 2.

Inclusion Criteria:

1. At the time of signing the informed consent, the participant must be 18 to 80 years of age, inclusive. 2. A diagnosis of ileal, ileocolonic, or colonic CD with an onset of symptoms for a minimum of 3 months prior to Screening as determined by the investigator based on clinical history, exclusion of other etiologies including infectious causes, and characteristic endoscopic and/or histologic findings. 3. Moderately to severely active CD defined by a CDAI score of 220 to 450 AND; CDAI LSF score ≥ 5 OR CDAI AP score ≥ 2; AND SES-CD of at least 6. 4. Participant had an inadequate response or intolerance to intervention with conventional treatment [oral aminosalicylates, oral CS, azathioprine, methotrexate, or 6-mercaptopurine], or prior biological treatment, or demonstrated CS dependence for the treatment of CD. For participants who have previously used biological treatment, a participant may have failed up to 3 biologics that include up to 2 different mechanisms of action. 5. Participants taking 5-aminosalicylates, Oral prednisone (or equivalent), Budesonide, Immunomodulators, Oral antibiotics, Immunomodulators, Probiotics must be at a stable dose. 6. Participant must have the QFT-TB test performed and meet the following TB criteria. A TB worksheet must also be completed: 1. Participant has no known history of active TB. 2. Participant has no known history of latent TB without completion of an appropriate course of intervention. 3. Meets 1 of the following acceptable TB test results: i. Negative QFT-TB obtained from central laboratory during Screening, OR ii. For a positive QFT-TB test obtained during Screening from the central laboratory, active TB must be ruled out or treated and negative QFT-TB confirmed by central laboratory OR iii. Indeterminate QFT-TB test obtained during the Screening Period from the central laboratory with ongoing QFT-TB testing as outlined in Appendix G. Participants with an indeterminate QFT-TB test can continue with Screening if they have all of the following: 1. no symptoms/risk factors per TB worksheet provided by the sponsor. 2. no known recent exposure to a case of active TB. 3. no evidence of active TB on chest x-ray within 8 weeks prior to Screening or during Screening. 4. confirmed QFT-TB negative by central laboratory. 7 Female participants of childbearing potential must have a negative urine pregnancy test prior to administration of study intervention and must agree to use a highly effective method of birth control (confirmed by the investigator) from randomization throughout the study duration and for at least 18 weeks after last dose of study intervention. 8 Women not of childbearing potential are defined as women who are either permanently sterilized or who are postmenopausal. Women will be considered postmenopausal if they have been amenorrhoeic for 12 months prior to the planned date of randomization without an alternative medical cause. 9 Nonsterilized males who are sexually active with a female partner of childbearing potential must comply with the methods of contraception during treatment and until the end of relevant systemic exposure in the male participant, plus a further 18 weeks. 10 Capable of giving signed informed consent, which includes compliance with the requirements and restrictions listed in the ICF and in the protocol. 11 Willingness and ability to attend all study visits, comply with the study procedures, read and write in order to complete questionnaires, and be able to complete the study period. 12 Provision of signed and dated written Optional Genetic Research Information informed consent prior to collection of samples for optional genetic research that supports Genomic Initiative. Complete inclusion criteria are in the study protocol.

Exclusion Criteria:

1. Participant is unable or unwilling to have endoscopic procedures performed during the study. 2. History or current diagnosis of ulcerative colitis, indeterminate colitis, microscopic colitis, ischemic colitis, colonic mucosal dysplasia, primary sclerosing cholangitis, or untreated bile acid malabsorption. 3. History of toxic megacolon within 3 months prior to Randomization. 4. Any intra-abdominal surgery, bowel resection, diversion, placement of ostomy or stoma within 3 months prior to Screening. Participants with a draining stoma, ostomy, or extensive colonic resection are excluded irrespective of the time from surgery. 5. Participant has an enterocutaneous or enterovesicular fistula. Participants with other active fistulas, including perianal fistulas, may be considered for enrollment if there is no anticipation for surgery and there is no evidence of active infection (eg, abscess). 6. Bowel perforation during the 6 months prior to Screening or evidence of obstruction within 3 months of Screening. 7. Complications of CD including short bowel syndrome, strictures/stenoses with obstruction or pre-stenotic dilation, or conditions where surgery may be anticipated within 6 months, or other conditions that may confound efficacy evaluations for the study. 8. Participant has any non-passable colonic stenosis/narrowing identified during the qualifying ileocolonoscopy (successful endoscope passage to the caecum with inability to enter the endoscope into the ileum is not covered under this exclusion criterion, and does not require exclusion). 9. Ongoing nutritional dependency for total parenteral nutrition or an elemental diet at Screening. 10. Participant has any of the following related to infections: • Evidence of a recent (within 6 months of Randomization) systemic fungal infection, requiring inpatient hospitalization, and/or antifungal treatment. • Any infection requiring hospitalization or treatment with IV anti-infectives (including antiviral treatment) within 4 weeks of Screening. • Cytomegalovirus or Epstein-Barr virus infection that has not resolved within 8 weeks prior to Screening • Clinically significant chronic infection (eg, osteomyelitis) that has not resolved within 8 weeks of Screening • Nonserious infection requiring oral anti-infectives within 2 weeks prior to randomization must be further discussed with the Study Physician/designee. • Participant has clinical evidence of or suspected to have an abscess during Screening. • Diagnosis of peritonitis or receiving treatment for peritonitis within 8 weeks prior to Screening • Participant has any underlying condition that predisposes participant to infections • Clinically significant active infection or signs/symptoms of infection that has the potential to worsen with immunosuppressive therapy • Signs or symptoms of ongoing infection due to intestinal pathogens. 11. Previous allogenic bone marrow transplant or history of organ or cell-based transplantation (eg, islet cell transplantation or autologous stem cell transplantation) with the exception of corneal transplant. 12. Chronic hepatitis B or C infection. 13. Known history of primary immunodeficiency, splenectomy, or any underlying condition that predisposes the subject to infection, includingHIV infection. 14. Prior history of or current diagnosis of a demyelinating disorder. 15. Participant has received the following treatment: • Adalimumab, certolizumab pegol, infliximab, or golimumab: within 8 weeks prior to Randomization • Vedolizumab or ustekinumab within 12 weeks prior to Randomization • Other prohibited medication, biologic or small molecule treatment within 5 half-lives prior to Randomization • Fecal microbiota transplantation: within 8 weeks prior to Screening ileocolonoscopy. 16. Except for ustekinumab, prior exposure to any biologic agent targeting IL-12 or IL-23. 17. Participants who received cyclosporine, mycophenolate mofetil, sirolimus (rapamycin), thalidomide, tacrolimus (FK-506), or tofacitinib within 2 weeks prior to Screening Visit 1. 18. Known history of allergy to the study intervention formulation or any of its excipients or components of the delivery device, or to any other biologic therapy. 19. Participants received more than 1 dose of IV or intramuscular steroids within 2 weeks prior to Screening Visit 1. 20. Participant received topical (rectal) aminosalicylic acid (eg, mesalamine) or topical (rectal) steroids within 2 weeks prior to Randomization. 21. Participant received a Bacille Calmette-Guérin vaccination within 12 months of Randomization or any other live vaccine less than 4 weeks prior to Randomization or is planning to receive any such vaccine over the course of the study. 22. Participant has known or suspected history of chronic use of NSAIDs (defined as at least 3 times per week for more than 3 months; not applicable to daily aspirin use up to 325mg per day) and/or opiates, drug, or alcohol abuse. 23. History of cancer with the following exceptions: (a) A history of basal cell carcinoma and/or squamous cell carcinoma of the skin, with apparent successful curative therapy greater than 12 months prior to Screening (b) Carcinoma in situ of the cervix, with apparent successful curative therapy, greater than 12 months prior to Screening. 24. Clinically significant cardiovascular conditions including recent myocardial infarction, unstable angina, stroke, transient ischemic attack, decompensated heart failure requiring hospitalization, or Class III/IV heart failure within 6 months of Screening. 25. Prolonged QTcF interval (QTc >450 msec or QTC >480 for participants with bundle branch block; determined on central ECG), or conditions leading to additional risk for QT prolongation (eg, congenital long-QT syndrome). 26. Clinically significant kidney disease. 27. Abnormal laboratory results at Screening. 28. Other concurrent medical conditions: Participant has known, preexisting, clinically significant endocrine, autoimmune, metabolic, neurologic, renal, gastrointestinal, hepatic, hematological, respiratory or any other system abnormalities that are not associated with CD and are uncontrolled with standard treatment. 29. Participant is currently enrolled in another investigational device or drug study, or is within 35 days or 5 half-lives, whichever is longer, since ending another investigational device or drug study, or receiving other investigational agent(s) 30. Transfusion of blood, plasma, or platelets within the 30 days prior to Screening. 31. Females who are pregnant, nursing, or planning a pregnancy during the study OR females who are of childbearing potential and do not agree to use a highly effective method of contraception consistently and correctly. 32. Employees of the clinical study site or any other individuals involved with the conduct of the study, or immediate family members of such individuals. 33. Previous randomization in the present study. . Complete exclusion criteria are in the study protocol

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT03759288
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Phase 2/Phase 3
Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

AstraZeneca
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

Kathy Bohannon
Principal Investigator Affiliation AstraZeneca
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Industry
Overall Status Recruiting
Countries Australia, Austria, Bulgaria, Canada, China, Czechia, France, Germany, Hungary, India, Israel, Italy, Korea, Republic of, Poland, Puerto Rico, Romania, Russian Federation, Slovakia, South Africa, Spain, Taiwan, Ukraine, United Kingdom, United States
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Crohn's Disease, IBD
Arms & Interventions

Arms

Experimental: (Stage 1) Brazikumab high dose

Intravenous Brazikumab on Days 1, 29, and 57, followed by subcutaneous Brazikumab on Day 85 and every 4 weeks through Week 48

Experimental: (Stage 1) Brazikumab low dose

Intravenous Brazikumab on Days 1, 29, and 57, followed by subcutaneous Brazikumab on Day 85 and every 4 weeks through Week 48

Placebo Comparator: (Stage 1) Placebo

Intravenous placebo on Days 1, 29, and 57, followed by subcutaneous placebo on Day 85 and every 4 weeks through Week 48

Experimental: (Stage 2) Brazikumab high dose

Intravenous Brazikumab on Days 1, 29, and 57, followed by subcutaneous Brazikumab on Day 85 and every 4 weeks through Week 48

Experimental: (Stage 2) Brazikumab low dose

Intravenous Brazikumab on Days 1, 29, and 57, followed by subcutaneous on Day 85 and every 4 weeks through Week 48

Active Comparator: (Stage 2) Humira®

Administered subcutaneously on Day 1, Day 15, and Day 29 and every 2 weeks through Week 50

Interventions

Drug: - Brazikumab low dose

Intravenous Brazikumab on Days 1, 29, and 57, followed by subcutaneous Brazikumab on Day 85 and every 4 weeks through Week 48

Drug: - Brazikumab high dose

Intravenous Brazikumab on Days 1, 29, and 57, followed by subcutaneous Brazikumab on Day 85 and every 4 weeks through Week 48

Drug: - Humira®

Administered subcutaneously on Day 1, Day 15, and Day 29 and every 2 weeks through Week 50.

Drug: - Placebo

Intravenous placebo on Days 1, 29, 57 followed by subcutaneous placebo on Day 85 and every 4 weeks through Week 48

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

Research Site, Mobile, Alabama

Status

Not yet recruiting

Address

Research Site

Mobile, Alabama, 36606

Research Site, Mesa, Arizona

Status

Withdrawn

Address

Research Site

Mesa, Arizona, 85206

Research Site, Phoenix, Arizona

Status

Not yet recruiting

Address

Research Site

Phoenix, Arizona, 85037

Research Site, Scottsdale, Arizona

Status

Withdrawn

Address

Research Site

Scottsdale, Arizona, 85258

Research Site, Scottsdale, Arizona

Status

Withdrawn

Address

Research Site

Scottsdale, Arizona, 85260

Research Site, Tucson, Arizona

Status

Withdrawn

Address

Research Site

Tucson, Arizona, 85741

Research Site, Little Rock, Arkansas

Status

Terminated

Address

Research Site

Little Rock, Arkansas, 72212

Research Site, Beverly Hills, California

Status

Withdrawn

Address

Research Site

Beverly Hills, California, 90211

Research Site, Camarillo, California

Status

Withdrawn

Address

Research Site

Camarillo, California, 93012

Research Site, Chula Vista, California

Status

Withdrawn

Address

Research Site

Chula Vista, California, 91911

Research Site, Garden Grove, California

Status

Withdrawn

Address

Research Site

Garden Grove, California, 92845

Research Site, La Mesa, California

Status

Withdrawn

Address

Research Site

La Mesa, California, 91942

Research Site, Lancaster, California

Status

Suspended

Address

Research Site

Lancaster, California, 93534

Research Site, Lincoln, California

Status

Completed

Address

Research Site

Lincoln, California, 95648

Research Site, Los Angeles, California

Status

Withdrawn

Address

Research Site

Los Angeles, California, 90036

Research Site, Los Angeles, California

Status

Withdrawn

Address

Research Site

Los Angeles, California, 90073

Research Site, Mission Hills, California

Status

Not yet recruiting

Address

Research Site

Mission Hills, California, 91345

Research Site, Newport Beach, California

Status

Not yet recruiting

Address

Research Site

Newport Beach, California, 92660

Research Site, Northridge, California

Status

Withdrawn

Address

Research Site

Northridge, California, 91324

Research Site, Poway, California

Status

Terminated

Address

Research Site

Poway, California, 92064

Research Site, San Bernardino, California

Status

Withdrawn

Address

Research Site

San Bernardino, California, 92408

Research Site, San Diego, California

Status

Terminated

Address

Research Site

San Diego, California, 92103

Research Site, San Francisco, California

Status

Withdrawn

Address

Research Site

San Francisco, California, 94127

Research Site, Colorado Springs, Colorado

Status

Suspended

Address

Research Site

Colorado Springs, Colorado, 80907

Research Site, Colorado Springs, Colorado

Status

Withdrawn

Address

Research Site

Colorado Springs, Colorado, 80909

Research Site, Boca Raton, Florida

Status

Terminated

Address

Research Site

Boca Raton, Florida, 33487

Research Site, Clearwater, Florida

Status

Active, not recruiting

Address

Research Site

Clearwater, Florida, 33756

Research Site, Coral Gables, Florida

Status

Withdrawn

Address

Research Site

Coral Gables, Florida, 33134

Research Site, Doral, Florida

Status

Withdrawn

Address

Research Site

Doral, Florida, 33166

Research Site, Gainesville, Florida

Status

Not yet recruiting

Address

Research Site

Gainesville, Florida, 32603

Research Site, Kissimmee, Florida

Status

Recruiting

Address

Research Site

Kissimmee, Florida, 34741

Research Site, Lakeland, Florida

Status

Recruiting

Address

Research Site

Lakeland, Florida, 33813

Research Site, Miami, Florida

Status

Recruiting

Address

Research Site

Miami, Florida, 33157

Research Site, Miami, Florida

Status

Recruiting

Address

Research Site

Miami, Florida, 33165

Research Site, Miami, Florida

Status

Withdrawn

Address

Research Site

Miami, Florida, 33165

Research Site, Miami, Florida

Status

Terminated

Address

Research Site

Miami, Florida, 33189

Research Site, Naples, Florida

Status

Not yet recruiting

Address

Research Site

Naples, Florida, 34102

Research Site, New Port Richey, Florida

Status

Recruiting

Address

Research Site

New Port Richey, Florida, 34653

Research Site, Ocoee, Florida

Status

Withdrawn

Address

Research Site

Ocoee, Florida, 34761

Research Site, Pensacola, Florida

Status

Recruiting

Address

Research Site

Pensacola, Florida, 32503

Research Site, Saint Petersburg, Florida

Status

Not yet recruiting

Address

Research Site

Saint Petersburg, Florida, 33709

Research Site, Saint Petersburg, Florida

Status

Terminated

Address

Research Site

Saint Petersburg, Florida, 33710

Research Site, Tampa, Florida

Status

Withdrawn

Address

Research Site

Tampa, Florida, 33606

Research Site, Tampa, Florida

Status

Active, not recruiting

Address

Research Site

Tampa, Florida, 33614

Research Site, Tampa, Florida

Status

Recruiting

Address

Research Site

Tampa, Florida, 33615

Research Site, Tampa, Florida

Status

Completed

Address

Research Site

Tampa, Florida, 33626

Research Site, Atlanta, Georgia

Status

Terminated

Address

Research Site

Atlanta, Georgia, 30328

Research Site, Atlanta, Georgia

Status

Not yet recruiting

Address

Research Site

Atlanta, Georgia, 30342

Research Site, Decatur, Georgia

Status

Recruiting

Address

Research Site

Decatur, Georgia, 30033

Research Site, Suwanee, Georgia

Status

Withdrawn

Address

Research Site

Suwanee, Georgia, 30024

Research Site, Arlington Heights, Illinois

Status

Withdrawn

Address

Research Site

Arlington Heights, Illinois, 60005

Research Site, Gurnee, Illinois

Status

Withdrawn

Address

Research Site

Gurnee, Illinois, 60031

Research Site, Oak Lawn, Illinois

Status

Not yet recruiting

Address

Research Site

Oak Lawn, Illinois, 60453

Research Site, Springfield, Illinois

Status

Not yet recruiting

Address

Research Site

Springfield, Illinois, 62702

Research Site, Brownsburg, Indiana

Status

Terminated

Address

Research Site

Brownsburg, Indiana, 46112

Research Site, New Albany, Indiana

Status

Withdrawn

Address

Research Site

New Albany, Indiana, 47150

Research Site, Iowa City, Iowa

Status

Withdrawn

Address

Research Site

Iowa City, Iowa, 52242

Research Site, Shawnee Mission, Kansas

Status

Withdrawn

Address

Research Site

Shawnee Mission, Kansas, 66226

Research Site, Topeka, Kansas

Status

Withdrawn

Address

Research Site

Topeka, Kansas, 66606

Research Site, Marrero, Louisiana

Status

Active, not recruiting

Address

Research Site

Marrero, Louisiana, 70072

Research Site, New Orleans, Louisiana

Status

Withdrawn

Address

Research Site

New Orleans, Louisiana, 70121

Research Site, Baltimore, Maryland

Status

Recruiting

Address

Research Site

Baltimore, Maryland, 21202

Research Site, Glen Burnie, Maryland

Status

Withdrawn

Address

Research Site

Glen Burnie, Maryland, 21061

Research Site, Rockville, Maryland

Status

Withdrawn

Address

Research Site

Rockville, Maryland, 20850

Research Site, Chesterfield, Michigan

Status

Active, not recruiting

Address

Research Site

Chesterfield, Michigan, 48047

Research Site, Farmington Hills, Michigan

Status

Withdrawn

Address

Research Site

Farmington Hills, Michigan, 48334

Research Site, Rochester, Minnesota

Status

Not yet recruiting

Address

Research Site

Rochester, Minnesota, 55905

Research Site, Biloxi, Mississippi

Status

Withdrawn

Address

Research Site

Biloxi, Mississippi, 39532

Research Site, Saint Louis, Missouri

Status

Withdrawn

Address

Research Site

Saint Louis, Missouri, 63141

Research Site, Lincoln, Nebraska

Status

Withdrawn

Address

Research Site

Lincoln, Nebraska, 68505

Research Site, Papillion, Nebraska

Status

Withdrawn

Address

Research Site

Papillion, Nebraska, 68046

Research Site, Henderson, Nevada

Status

Withdrawn

Address

Research Site

Henderson, Nevada, 89052

Research Site, Las Vegas, Nevada

Status

Withdrawn

Address

Research Site

Las Vegas, Nevada, 89106

Research Site, Las Vegas, Nevada

Status

Terminated

Address

Research Site

Las Vegas, Nevada, 89123

Research Site, Albuquerque, New Mexico

Status

Completed

Address

Research Site

Albuquerque, New Mexico, 87108

Research Site, Brooklyn, New York

Status

Withdrawn

Address

Research Site

Brooklyn, New York, 11218

Research Site, Brooklyn, New York

Status

Withdrawn

Address

Research Site

Brooklyn, New York, 11235

Research Site, New York, New York

Status

Withdrawn

Address

Research Site

New York, New York, 10016

Research Site, Rochester, New York

Status

Not yet recruiting

Address

Research Site

Rochester, New York, 14642

Research Site, Sunnyside, New York

Status

Withdrawn

Address

Research Site

Sunnyside, New York, 11104

Research Site, Greenville, North Carolina

Status

Recruiting

Address

Research Site

Greenville, North Carolina, 27834

Research Site, Morehead City, North Carolina

Status

Terminated

Address

Research Site

Morehead City, North Carolina, 28557

Research Site, Beachwood, Ohio

Status

Completed

Address

Research Site

Beachwood, Ohio, 44122

Research Site, Beavercreek, Ohio

Status

Withdrawn

Address

Research Site

Beavercreek, Ohio, 45431

Research Site, Beavercreek, Ohio

Status

Withdrawn

Address

Research Site

Beavercreek, Ohio, 45440

Research Site, Cincinnati, Ohio

Status

Withdrawn

Address

Research Site

Cincinnati, Ohio, 45219

Research Site, Cincinnati, Ohio

Status

Withdrawn

Address

Research Site

Cincinnati, Ohio, 45236

Research Site, Mentor, Ohio

Status

Withdrawn

Address

Research Site

Mentor, Ohio, 44060

Research Site, Springfield, Ohio

Status

Withdrawn

Address

Research Site

Springfield, Ohio, 45503

Research Site, Oklahoma City, Oklahoma

Status

Recruiting

Address

Research Site

Oklahoma City, Oklahoma, 73102

Research Site, Oklahoma City, Oklahoma

Status

Withdrawn

Address

Research Site

Oklahoma City, Oklahoma, 73112

Research Site, Oklahoma City, Oklahoma

Status

Withdrawn

Address

Research Site

Oklahoma City, Oklahoma, 73118

Research Site, Tulsa, Oklahoma

Status

Withdrawn

Address

Research Site

Tulsa, Oklahoma, 74104

Research Site, Tulsa, Oklahoma

Status

Withdrawn

Address

Research Site

Tulsa, Oklahoma, 74145

Research Site, Uniontown, Pennsylvania

Status

Active, not recruiting

Address

Research Site

Uniontown, Pennsylvania, 15401

Research Site, Anderson, South Carolina

Status

Withdrawn

Address

Research Site

Anderson, South Carolina, 29621

Research Site, Greenville, South Carolina

Status

Withdrawn

Address

Research Site

Greenville, South Carolina, 29615

Research Site, Greer, South Carolina

Status

Withdrawn

Address

Research Site

Greer, South Carolina, 29650

Research Site, Orangeburg, South Carolina

Status

Withdrawn

Address

Research Site

Orangeburg, South Carolina, 29118

Research Site, Johnson City, Tennessee

Status

Withdrawn

Address

Research Site

Johnson City, Tennessee, 37604

Research Site, Amarillo, Texas

Status

Withdrawn

Address

Research Site

Amarillo, Texas, 79109

Research Site, Austin, Texas

Status

Withdrawn

Address

Research Site

Austin, Texas, 78726

Research Site, Carrollton, Texas

Status

Terminated

Address

Research Site

Carrollton, Texas, 75007

Research Site, Dallas, Texas

Status

Withdrawn

Address

Research Site

Dallas, Texas, 75234

Research Site, Houston, Texas

Status

Terminated

Address

Research Site

Houston, Texas, 77017

Research Site, Houston, Texas

Status

Not yet recruiting

Address

Research Site

Houston, Texas, 77030

Research Site, Houston, Texas

Status

Withdrawn

Address

Research Site

Houston, Texas, 77030

Research Site, Houston, Texas

Status

Recruiting

Address

Research Site

Houston, Texas, 77034

Research Site, Houston, Texas

Status

Withdrawn

Address

Research Site

Houston, Texas, 77044

Research Site, Houston, Texas

Status

Completed

Address

Research Site

Houston, Texas, 77058

Research Site, McAllen, Texas

Status

Terminated

Address

Research Site

McAllen, Texas, 78503

Research Site, McKinney, Texas

Status

Recruiting

Address

Research Site

McKinney, Texas, 75071

Research Site, Pflugerville, Texas

Status

Terminated

Address

Research Site

Pflugerville, Texas, 78660

Research Site, San Antonio, Texas

Status

Recruiting

Address

Research Site

San Antonio, Texas, 78229

Research Site, San Antonio, Texas

Status

Withdrawn

Address

Research Site

San Antonio, Texas, 78258

Research Site, Spring, Texas

Status

Withdrawn

Address

Research Site

Spring, Texas, 77386

Research Site, Stafford, Texas

Status

Recruiting

Address

Research Site

Stafford, Texas, 77477

Research Site, Bountiful, Utah

Status

Withdrawn

Address

Research Site

Bountiful, Utah, 84010

Research Site, Ogden, Utah

Status

Withdrawn

Address

Research Site

Ogden, Utah, 84405

Research Site, Salt Lake City, Utah

Status

Not yet recruiting

Address

Research Site

Salt Lake City, Utah, 84132

Research Site, North Chesterfield, Virginia

Status

Terminated

Address

Research Site

North Chesterfield, Virginia, 23236

Research Site, Seattle, Washington

Status

Withdrawn

Address

Research Site

Seattle, Washington, 98195

Research Site, Spokane, Washington

Status

Not yet recruiting

Address

Research Site

Spokane, Washington, 99204

Research Site, Huntington, West Virginia

Status

Recruiting

Address

Research Site

Huntington, West Virginia, 25701

International Sites

Research Site, Macquarie University, Australia

Status

Withdrawn

Address

Research Site

Macquarie University, , 2109

Research Site, Murdoch, Australia

Status

Withdrawn

Address

Research Site

Murdoch, , 6150

Research Site, Innsbruck, Austria

Status

Withdrawn

Address

Research Site

Innsbruck, , 6020

Research Site, Ried, Austria

Status

Withdrawn

Address

Research Site

Ried, , 4910

Research Site, Steyr, Austria

Status

Not yet recruiting

Address

Research Site

Steyr, , 4400

Research Site, Wels, Austria

Status

Not yet recruiting

Address

Research Site

Wels, , 4600

Research Site, Plovdiv, Bulgaria

Status

Withdrawn

Address

Research Site

Plovdiv, , 4002

Research Site, New Westminster, British Columbia, Canada

Status

Recruiting

Address

Research Site

New Westminster, British Columbia, V3L 3W4

Research Site, Barrie, Ontario, Canada

Status

Withdrawn

Address

Research Site

Barrie, Ontario, L4M 7G1

Research Site, Hamilton, Ontario, Canada

Status

Recruiting

Address

Research Site

Hamilton, Ontario, L8S 4K1

Research Site, Ottawa, Ontario, Canada

Status

Withdrawn

Address

Research Site

Ottawa, Ontario, K1H 8L6

Research Site, Toronto, Ontario, Canada

Status

Withdrawn

Address

Research Site

Toronto, Ontario, M3M 0B2

Research Site, Toronto, Ontario, Canada

Status

Withdrawn

Address

Research Site

Toronto, Ontario, M5T 2S8

Research Site, Vaughan, Ontario, Canada

Status

Withdrawn

Address

Research Site

Vaughan, Ontario, L4L 4Y7

Research Site, Chicoutimi, Quebec, Canada

Status

Not yet recruiting

Address

Research Site

Chicoutimi, Quebec, G7H 5H6

Research Site, Montreal, Quebec, Canada

Status

Withdrawn

Address

Research Site

Montreal, Quebec, H1M 1B1

Research Site, Beijing, China

Status

Withdrawn

Address

Research Site

Beijing, , 100032

Research Site, Beijing, China

Status

Withdrawn

Address

Research Site

Beijing, , 100034

Research Site, Chengdu, China

Status

Withdrawn

Address

Research Site

Chengdu, , 610072

Research Site, Chongqing, China

Status

Withdrawn

Address

Research Site

Chongqing, , 400010

Research Site, Guangzhou, China

Status

Withdrawn

Address

Research Site

Guangzhou, , 510100

Research Site, Haidian District, China

Status

Withdrawn

Address

Research Site

Haidian District, , 100191

Research Site, Nanjing, China

Status

Withdrawn

Address

Research Site

Nanjing, , 210029

Research Site, Shanghai, China

Status

Withdrawn

Address

Research Site

Shanghai, , 200080

Research Site, Shanghai, China

Status

Withdrawn

Address

Research Site

Shanghai, , CN-200120

Research Site, Shanghai, China

Status

Withdrawn

Address

Research Site

Shanghai, ,

Research Site, Shenzhen, China

Status

Withdrawn

Address

Research Site

Shenzhen, , 518053

Research Site, Shiyan, China

Status

Withdrawn

Address

Research Site

Shiyan, , 442005

Research Site, Suzhou, China

Status

Withdrawn

Address

Research Site

Suzhou, , 215006

Research Site, Wuhan, China

Status

Withdrawn

Address

Research Site

Wuhan, , 430060

Research Site, Wuxi, China

Status

Withdrawn

Address

Research Site

Wuxi, , 214023

Research Site, Brno, Czechia

Status

Withdrawn

Address

Research Site

Brno, , 636 00

Research Site, Ceske Budejovice, Czechia

Status

Not yet recruiting

Address

Research Site

Ceske Budejovice, , 370 01

Research Site, Horovice, Czechia

Status

Recruiting

Address

Research Site

Horovice, , 268 31

Research Site, Hradec Kralove, Czechia

Status

Recruiting

Address

Research Site

Hradec Kralove, , 500 12

Research Site, Ostrava, Czechia

Status

Recruiting

Address

Research Site

Ostrava, , 702 00

Research Site, Praha 2, Czechia

Status

Withdrawn

Address

Research Site

Praha 2, , 120 00

Research Site, Usti nad Labem, Czechia

Status

Suspended

Address

Research Site

Usti nad Labem, , 401 13

Research Site, Amiens Cedex 1, France

Status

Not yet recruiting

Address

Research Site

Amiens Cedex 1, , 80054

Research Site, Bayonne, France

Status

Withdrawn

Address

Research Site

Bayonne, , 64100

Research Site, Clermond Ferrand, France

Status

Not yet recruiting

Address

Research Site

Clermond Ferrand, , 63003

Research Site, Clichy Cedex, France

Status

Not yet recruiting

Address

Research Site

Clichy Cedex, , 92118

Research Site, Montpellier Cedex 5, France

Status

Not yet recruiting

Address

Research Site

Montpellier Cedex 5, , 34295

Research Site, Nice, France

Status

Not yet recruiting

Address

Research Site

Nice, , 06200

Research Site, Paris, France

Status

Not yet recruiting

Address

Research Site

Paris, , 75018

Research Site, Reims, France

Status

Not yet recruiting

Address

Research Site

Reims, , 51092

Research Site, Saint Priest en Jarez, France

Status

Withdrawn

Address

Research Site

Saint Priest en Jarez, , 42270

Research Site, Augsburg, Germany

Status

Recruiting

Address

Research Site

Augsburg, , 86156

Research Site, Berlin, Germany

Status

Withdrawn

Address

Research Site

Berlin, , 10117

Research Site, Berlin, Germany

Status

Recruiting

Address

Research Site

Berlin, , 10825

Research Site, Berlin, Germany

Status

Withdrawn

Address

Research Site

Berlin, , 12627

Research Site, Bremen, Germany

Status

Withdrawn

Address

Research Site

Bremen, , 28177

Research Site, Dessau-Rosslau, Germany

Status

Withdrawn

Address

Research Site

Dessau-Rosslau, , 6847

Research Site, Dortmund, Germany

Status

Withdrawn

Address

Research Site

Dortmund, , 44137

Research Site, Frankfurt, Germany

Status

Withdrawn

Address

Research Site

Frankfurt, , 60313

Research Site, Hamburg, Germany

Status

Recruiting

Address

Research Site

Hamburg, , 20251

Research Site, Hamburg, Germany

Status

Withdrawn

Address

Research Site

Hamburg, , 22297

Research Site, Hannover, Germany

Status

Withdrawn

Address

Research Site

Hannover, , 30459

Research Site, Kiel, Germany

Status

Recruiting

Address

Research Site

Kiel, , 24105

Research Site, Leipzig, Germany

Status

Withdrawn

Address

Research Site

Leipzig, , 04103

Research Site, Minden, Germany

Status

Recruiting

Address

Research Site

Minden, , 32423

Research Site, Munich, Germany

Status

Withdrawn

Address

Research Site

Munich, , 80331

Research Site, Neuruppin, Germany

Status

Withdrawn

Address

Research Site

Neuruppin, , 16816

Research Site, Remscheid, Germany

Status

Recruiting

Address

Research Site

Remscheid, , 42859

Research Site, Ulm, Germany

Status

Recruiting

Address

Research Site

Ulm, , 89081

Research Site, Weiden In Der Oberpfalz, Germany

Status

Withdrawn

Address

Research Site

Weiden In Der Oberpfalz, , 92637

Research Site, Budapest, Hungary

Status

Suspended

Address

Research Site

Budapest, , 1033

Research Site, Budapest, Hungary

Status

Recruiting

Address

Research Site

Budapest, , 1082

Research Site, Debrecen, Hungary

Status

Not yet recruiting

Address

Research Site

Debrecen, , 4032

Research Site, Gyöngyös, Hungary

Status

Withdrawn

Address

Research Site

Gyöngyös, , 3200

Research Site, Kecskemét, Hungary

Status

Recruiting

Address

Research Site

Kecskemét, , 6000

Research Site, Szeged, Hungary

Status

Withdrawn

Address

Research Site

Szeged, , 6725

Research Site, Szekszárd, Hungary

Status

Withdrawn

Address

Research Site

Szekszárd, , 7100

Research Site, Ahemdabad, India

Status

Withdrawn

Address

Research Site

Ahemdabad, , 380054

Research Site, Ahemdabad, India

Status

Not yet recruiting

Address

Research Site

Ahemdabad, , 380054

Research Site, Ahmedabad, India

Status

Withdrawn

Address

Research Site

Ahmedabad, , 380006

Research Site, Ahmedabad, India

Status

Withdrawn

Address

Research Site

Ahmedabad, , 380052

Research Site, Assam, India

Status

Withdrawn

Address

Research Site

Assam, , 781006

Research Site, Bangalore, India

Status

Withdrawn

Address

Research Site

Bangalore, , 560054

Research Site, Bangalore, India

Status

Not yet recruiting

Address

Research Site

Bangalore, , 560054

Research Site, Gandhinagar, India

Status

Withdrawn

Address

Research Site

Gandhinagar, , 382428

Research Site, Hyderabad, India

Status

Withdrawn

Address

Research Site

Hyderabad, , 500032

Research Site, Hyderabad, India

Status

Not yet recruiting

Address

Research Site

Hyderabad, , 500032

Research Site, Hyderabad, India

Status

Withdrawn

Address

Research Site

Hyderabad, , 500058

Research Site, Jaipur, India

Status

Withdrawn

Address

Research Site

Jaipur, , 302001

Research Site, Jaipur, India

Status

Not yet recruiting

Address

Research Site

Jaipur, , 302001

Research Site, Jaipur, India

Status

Withdrawn

Address

Research Site

Jaipur, , 302004

Research Site, Kolkatta, India

Status

Withdrawn

Address

Research Site

Kolkatta, , 700026

Research Site, Nagpur, India

Status

Withdrawn

Address

Research Site

Nagpur, , 440010

Research Site, New Dehli, India

Status

Withdrawn

Address

Research Site

New Dehli, , 110029

Research Site, New Delhi, India

Status

Withdrawn

Address

Research Site

New Delhi, , 110017

Research Site, New Delhi, India

Status

Not yet recruiting

Address

Research Site

New Delhi, , 110017

Research Site, New Delhi, India

Status

Withdrawn

Address

Research Site

New Delhi, , 110075

Research Site, New Delhi, India

Status

Not yet recruiting

Address

Research Site

New Delhi, , 110075

Research Site, Pune, India

Status

Withdrawn

Address

Research Site

Pune, , 411001

Research Site, Rajkot, India

Status

Withdrawn

Address

Research Site

Rajkot, , 360004

Research Site, Rajkot, India

Status

Not yet recruiting

Address

Research Site

Rajkot, , 360004

Research Site, Secunderabad, India

Status

Withdrawn

Address

Research Site

Secunderabad, , 500003

Research Site, Secunderabad, India

Status

Not yet recruiting

Address

Research Site

Secunderabad, , 500003

Research Site, Surat, India

Status

Withdrawn

Address

Research Site

Surat, , 395002

Research Site, Surat, India

Status

Not yet recruiting

Address

Research Site

Surat, , 395002

Research Site, Wardha, India

Status

Withdrawn

Address

Research Site

Wardha, , 442004

Research Site, Wardha, India

Status

Not yet recruiting

Address

Research Site

Wardha, , 442004

Research Site, Haifa, Israel

Status

Withdrawn

Address

Research Site

Haifa, , 31048

Research Site, Haifa, Israel

Status

Withdrawn

Address

Research Site

Haifa, , 3109601

Research Site, HaIFA, Israel

Status

Recruiting

Address

Research Site

HaIFA, , 3109601

Research Site, Jerusalem, Israel

Status

Not yet recruiting

Address

Research Site

Jerusalem, , 9103102

Research Site, Jerusalem, Israel

Status

Withdrawn

Address

Research Site

Jerusalem, , 9362410

Research Site, Kfar Saba, Israel

Status

Not yet recruiting

Address

Research Site

Kfar Saba, , 44218

Research Site, Nazareth, Israel

Status

Not yet recruiting

Address

Research Site

Nazareth, , 16100

Research Site, Petah Tikva, Israel

Status

Not yet recruiting

Address

Research Site

Petah Tikva, , 4941492

Research Site, Ramat Gan, Israel

Status

Withdrawn

Address

Research Site

Ramat Gan, , 52621

Research Site, Rehovot, Israel

Status

Withdrawn

Address

Research Site

Rehovot, , 76100

Research Site, Tel Aviv, Israel

Status

Withdrawn

Address

Research Site

Tel Aviv, , 0

Research Site, Belluno, Italy

Status

Not yet recruiting

Address

Research Site

Belluno, , 32100

Research Site, Bologna, Italy

Status

Not yet recruiting

Address

Research Site

Bologna, , 40138

Research Site, Caltanissetta, Italy

Status

Withdrawn

Address

Research Site

Caltanissetta, , 93100

Research Site, Caserta, Italy

Status

Withdrawn

Address

Research Site

Caserta, , 81100

Research Site, Castellana Grotte, Italy

Status

Not yet recruiting

Address

Research Site

Castellana Grotte, , 70013

Research Site, Chieti, Italy

Status

Withdrawn

Address

Research Site

Chieti, , 66100

Research Site, Firenze, Italy

Status

Not yet recruiting

Address

Research Site

Firenze, , 50134

Research Site, Foggia, Italy

Status

Withdrawn

Address

Research Site

Foggia, , 71100

Research Site, Garbagnate Milanese, Italy

Status

Recruiting

Address

Research Site

Garbagnate Milanese, , 20024

Research Site, L Aquila, Italy

Status

Not yet recruiting

Address

Research Site

L Aquila, , 67100

Research Site, Milano, Italy

Status

Not yet recruiting

Address

Research Site

Milano, , 20132

Research Site, Milano, Italy

Status

Not yet recruiting

Address

Research Site

Milano, , 20154

Research Site, Naples, Italy

Status

Withdrawn

Address

Research Site

Naples, , 80138

Research Site, Napoli, Italy

Status

Not yet recruiting

Address

Research Site

Napoli, , 80131

Research Site, Padova, Italy

Status

Not yet recruiting

Address

Research Site

Padova, , 35128

Research Site, Palermo, Italy

Status

Not yet recruiting

Address

Research Site

Palermo, , 90127

Research Site, Pavia, Italy

Status

Recruiting

Address

Research Site

Pavia, , 27100

Research Site, Roma, Italy

Status

Not yet recruiting

Address

Research Site

Roma, , 00157

Research Site, Roma, Italy

Status

Withdrawn

Address

Research Site

Roma, , 00168

Research Site, Rozzano, Italy

Status

Not yet recruiting

Address

Research Site

Rozzano, , 20089

Research Site, Salerno, Italy

Status

Withdrawn

Address

Research Site

Salerno, , 84131

Research Site, Busan, Korea, Republic of

Status

Recruiting

Address

Research Site

Busan, , 48108

Research Site, Daegu, Korea, Republic of

Status

Recruiting

Address

Research Site

Daegu, , 42415

Research Site, Seoul, Korea, Republic of

Status

Withdrawn

Address

Research Site

Seoul, , 03181

Research Site, Seoul, Korea, Republic of

Status

Recruiting

Address

Research Site

Seoul, , 03722

Research Site, Seoul, Korea, Republic of

Status

Recruiting

Address

Research Site

Seoul, , 06351

Research Site, Seoul, Korea, Republic of

Status

Recruiting

Address

Research Site

Seoul, , 06591

Research Site, Seoul, Korea, Republic of

Status

Recruiting

Address

Research Site

Seoul, , 156-755

Research Site, Wonju-si, Korea, Republic of

Status

Recruiting

Address

Research Site

Wonju-si, , 26426

Research Site, Białystok, Poland

Status

Not yet recruiting

Address

Research Site

Białystok, , 15-276

Research Site, Bydgoszcz, Poland

Status

Recruiting

Address

Research Site

Bydgoszcz, , 85 168

Research Site, Bydgoszcz, Poland

Status

Recruiting

Address

Research Site

Bydgoszcz, , 85-079

Research Site, Chojnice, Poland

Status

Recruiting

Address

Research Site

Chojnice, , 89-600

Research Site, Częstochowa, Poland

Status

Withdrawn

Address

Research Site

Częstochowa, , 42-202

Research Site, Gdańsk, Poland

Status

Withdrawn

Address

Research Site

Gdańsk, , 80-382

Research Site, Katowice, Poland

Status

Withdrawn

Address

Research Site

Katowice, , 40-752

Research Site, Kielce, Poland

Status

Recruiting

Address

Research Site

Kielce, , 25-355

Research Site, Końskie, Poland

Status

Withdrawn

Address

Research Site

Końskie, , 26-200

Research Site, Krakow, Poland

Status

Withdrawn

Address

Research Site

Krakow, , 31-501

Research Site, Kraków, Poland

Status

Recruiting

Address

Research Site

Kraków, , 31-513

Research Site, Mysłowice, Poland

Status

Withdrawn

Address

Research Site

Mysłowice, , 41-400

Research Site, Nowa Sól, Poland

Status

Withdrawn

Address

Research Site

Nowa Sól, , 67-100

Research Site, Nowy Targ, Poland

Status

Withdrawn

Address

Research Site

Nowy Targ, , 34-400

Research Site, Poznan, Poland

Status

Withdrawn

Address

Research Site

Poznan, , 60-529

Research Site, Poznań, Poland

Status

Withdrawn

Address

Research Site

Poznań, , 60-702

Research Site, Pruszków, Poland

Status

Withdrawn

Address

Research Site

Pruszków, , 05-800

Research Site, Rzeszow, Poland

Status

Recruiting

Address

Research Site

Rzeszow, , 35-302

Research Site, Sopot, Poland

Status

Recruiting

Address

Research Site

Sopot, , 81-756

Research Site, Szczecin, Poland

Status

Withdrawn

Address

Research Site

Szczecin, , 71-434

Research Site, Toruń, Poland

Status

Recruiting

Address

Research Site

Toruń, , 87-100

Research Site, Warszawa, Poland

Status

Recruiting

Address

Research Site

Warszawa, , 00-635

Research Site, Warszawa, Poland

Status

Not yet recruiting

Address

Research Site

Warszawa, , 02-507

Research Site, Warszawa, Poland

Status

Recruiting

Address

Research Site

Warszawa, , 03-580

Research Site, Wroclaw, Poland

Status

Withdrawn

Address

Research Site

Wroclaw, , 51-162

Research Site, Wroclaw, Poland

Status

Withdrawn

Address

Research Site

Wroclaw, , 51-685

Research Site, Wrocław, Poland

Status

Withdrawn

Address

Research Site

Wrocław, , 50-449

Research Site, Wrocław, Poland

Status

Recruiting

Address

Research Site

Wrocław, , 52-210

Research Site, Łódź, Poland

Status

Withdrawn

Address

Research Site

Łódź, , 90-302

Research Site, Łódź, Poland

Status

Withdrawn

Address

Research Site

Łódź, , 93-338

Research Site, San Juan, Puerto Rico

Status

Recruiting

Address

Research Site

San Juan, , 00927

Research Site, Bucharest, Romania

Status

Withdrawn

Address

Research Site

Bucharest, , 020125

Research Site, Aramil, Russian Federation

Status

Suspended

Address

Research Site

Aramil, , 624002

Research Site, Izhevsk, Russian Federation

Status

Suspended

Address

Research Site

Izhevsk, , 426035

Research Site, Kazan, Russian Federation

Status

Suspended

Address

Research Site

Kazan, , 420008

Research Site, Kemerovo, Russian Federation

Status

Suspended

Address

Research Site

Kemerovo, , 650000

Research Site, Krasnodar, Russian Federation

Status

Suspended

Address

Research Site

Krasnodar, , 350072

Research Site, Moscow, Russian Federation

Status

Suspended

Address

Research Site

Moscow, , 115419

Research Site, Novosibirsk, Russian Federation

Status

Suspended

Address

Research Site

Novosibirsk, , 630007

Research Site, Perm, Russian Federation

Status

Suspended

Address

Research Site

Perm, , 614000

Research Site, Pyatigorsk, Russian Federation

Status

Withdrawn

Address

Research Site

Pyatigorsk, , 357500

Research Site, Saint-Petersburg, Russian Federation

Status

Suspended

Address

Research Site

Saint-Petersburg, , 195257

Research Site, Saint-Petersburg, Russian Federation

Status

Suspended

Address

Research Site

Saint-Petersburg, , 196143

Research Site, Tomsk, Russian Federation

Status

Suspended

Address

Research Site

Tomsk, , 634050

Research Site, Velikiy Novgorod, Russian Federation

Status

Withdrawn

Address

Research Site

Velikiy Novgorod, , 173008

Research Site, Banska Bystrica, Slovakia

Status

Recruiting

Address

Research Site

Banska Bystrica, , 97401

Research Site, Banska Bystrica, Slovakia

Status

Withdrawn

Address

Research Site

Banska Bystrica, , 97405

Research Site, Bratislava, Slovakia

Status

Not yet recruiting

Address

Research Site

Bratislava, , 81108

Research Site, Bratislava, Slovakia

Status

Withdrawn

Address

Research Site

Bratislava, , 82007

Research Site, Bratislava, Slovakia

Status

Withdrawn

Address

Research Site

Bratislava, , 83103

Research Site, Bratislava, Slovakia

Status

Recruiting

Address

Research Site

Bratislava, , 851 07

Research Site, Kosice, Slovakia

Status

Recruiting

Address

Research Site

Kosice, , 04013

Research Site, Nitra, Slovakia

Status

Recruiting

Address

Research Site

Nitra, , 94901

Research Site, Presov, Slovakia

Status

Withdrawn

Address

Research Site

Presov, , 08001

Research Site, Bloemfontein, South Africa

Status

Recruiting

Address

Research Site

Bloemfontein, , 9301

Research Site, Bloemfontein, South Africa

Status

Withdrawn

Address

Research Site

Bloemfontein, , 9301

Research Site, Cape Town, South Africa

Status

Withdrawn

Address

Research Site

Cape Town, , 1730

Research Site, Cape Town, South Africa

Status

Recruiting

Address

Research Site

Cape Town, , 7500

Research Site, Cape Town, South Africa

Status

Not yet recruiting

Address

Research Site

Cape Town, , 7708

Research Site, Johannesburg, South Africa

Status

Withdrawn

Address

Research Site

Johannesburg, , 1827

Research Site, Johannesburg, South Africa

Status

Recruiting

Address

Research Site

Johannesburg, , 1827

Research Site, Johannesburg, South Africa

Status

Withdrawn

Address

Research Site

Johannesburg, , 2193

Research Site, Plumstead, South Africa

Status

Withdrawn

Address

Research Site

Plumstead, , 7800

Research Site, Plumstead, South Africa

Status

Recruiting

Address

Research Site

Plumstead, , 7800

Research Site, Port Elizabeth, South Africa

Status

Withdrawn

Address

Research Site

Port Elizabeth, , 6001

Research Site, Pretoria, South Africa

Status

Recruiting

Address

Research Site

Pretoria, , 0002

Research Site, Madrid, Spain

Status

Recruiting

Address

Research Site

Madrid, , 28046

Research Site, Pamplona, Spain

Status

Recruiting

Address

Research Site

Pamplona, , 31008

Research Site, Pontevedra, Spain

Status

Recruiting

Address

Research Site

Pontevedra, , 36071

Research Site, Sevilla, Spain

Status

Withdrawn

Address

Research Site

Sevilla, , 41013

Research Site, Sevilla, Spain

Status

Recruiting

Address

Research Site

Sevilla, , 41071

Research Site, Tomelloso, Spain

Status

Recruiting

Address

Research Site

Tomelloso, , 13700

Research Site, Valencia, Spain

Status

Recruiting

Address

Research Site

Valencia, , 46010

Research Site, Kaohsiung, Taiwan

Status

Recruiting

Address

Research Site

Kaohsiung, , 80756

Research Site, Taichung, Taiwan

Status

Recruiting

Address

Research Site

Taichung, , 40201

Research Site, Taichung, Taiwan

Status

Recruiting

Address

Research Site

Taichung, , 40447

Research Site, Taipei City, Taiwan

Status

Recruiting

Address

Research Site

Taipei City, , 114

Research Site, Taipei, Taiwan

Status

Recruiting

Address

Research Site

Taipei, , 100

Research Site, Taipei, Taiwan

Status

Recruiting

Address

Research Site

Taipei, , 11217

Research Site, Dnipro, Ukraine

Status

Withdrawn

Address

Research Site

Dnipro, , 49000

Research Site, Ivano-Frankivsk, Ukraine

Status

Withdrawn

Address

Research Site

Ivano-Frankivsk, ,

Research Site, Kharkiv, Ukraine

Status

Suspended

Address

Research Site

Kharkiv, , 61037

Research Site, Kherson, Ukraine

Status

Suspended

Address

Research Site

Kherson, , 73000

Research Site, Kyiv, Ukraine

Status

Suspended

Address

Research Site

Kyiv, , 01023

Research Site, Kyiv, Ukraine

Status

Withdrawn

Address

Research Site

Kyiv, , 01030

Research Site, Kyiv, Ukraine

Status

Withdrawn

Address

Research Site

Kyiv, , 01033

Research Site, Kyiv, Ukraine

Status

Withdrawn

Address

Research Site

Kyiv, , 02002

Research Site, Kyiv, Ukraine

Status

Withdrawn

Address

Research Site

Kyiv, , 02132

Research Site, Kyiv, Ukraine

Status

Withdrawn

Address

Research Site

Kyiv, , 03037

Research Site, Kyiv, Ukraine

Status

Suspended

Address

Research Site

Kyiv, , 03680

Research Site, Kyiv, Ukraine

Status

Suspended

Address

Research Site

Kyiv, , 04050

Research Site, Kyiv, Ukraine

Status

Suspended

Address

Research Site

Kyiv, , 04078

Research Site, Kyiv, Ukraine

Status

Withdrawn

Address

Research Site

Kyiv, , 1049

Research Site, Kyiv, Ukraine

Status

Withdrawn

Address

Research Site

Kyiv, , 4107

Research Site, Lviv, Ukraine

Status

Suspended

Address

Research Site

Lviv, , 79059

Research Site, Odesa, Ukraine

Status

Withdrawn

Address

Research Site

Odesa, , 65114

Research Site, Poltava, Ukraine

Status

Withdrawn

Address

Research Site

Poltava, , 36011

Research Site, Ternopil, Ukraine

Status

Suspended

Address

Research Site

Ternopil, , 46001

Research Site, Uzhhorod, Ukraine

Status

Not yet recruiting

Address

Research Site

Uzhhorod, , 88018

Research Site, Vinnytsia, Ukraine

Status

Withdrawn

Address

Research Site

Vinnytsia, , 21001

Research Site, Vinnytsia, Ukraine

Status

Suspended

Address

Research Site

Vinnytsia, , 21009

Research Site, Vinnytsya, Ukraine

Status

Not yet recruiting

Address

Research Site

Vinnytsya, , 21028

Research Site, Zaporizhzhia, Ukraine

Status

Withdrawn

Address

Research Site

Zaporizhzhia, , 69600

Research Site, Cardiff, United Kingdom

Status

Withdrawn

Address

Research Site

Cardiff, , CF14 5GJ

Research Site, Chorley, United Kingdom

Status

Withdrawn

Address

Research Site

Chorley, , PR7 7NA

Research Site, Coventry, United Kingdom

Status

Not yet recruiting

Address

Research Site

Coventry, , CV2 2DX

Research Site, Edgbaston, United Kingdom

Status

Withdrawn

Address

Research Site

Edgbaston, , B15 2SQ

Research Site, Epsom, United Kingdom

Status

Withdrawn

Address

Research Site

Epsom, , KT18 7EG

Research Site, Glasgow, United Kingdom

Status

Withdrawn

Address

Research Site

Glasgow, , G20 OSP

Research Site, Hexham, United Kingdom

Status

Withdrawn

Address

Research Site

Hexham, , NE46 1QJ

Research Site, Liverpool, United Kingdom

Status

Withdrawn

Address

Research Site

Liverpool, , L22 0LG

Research Site, Manchester, United Kingdom

Status

Withdrawn

Address

Research Site

Manchester, , M15 6SX

Research Site, Nottingham, United Kingdom

Status

Not yet recruiting

Address

Research Site

Nottingham, , NG7 2UH

Research Site, Reading, United Kingdom

Status

Withdrawn

Address

Research Site

Reading, , RG2 0TG

Research Site, Stockton, United Kingdom

Status

Withdrawn

Address

Research Site

Stockton, , TS19 8PE

Research Site, West Bromwich, United Kingdom

Status

Not yet recruiting

Address

Research Site

West Bromwich, , B71 4HJ

The content provided on clinical trials is for informational purposes only and is not a substitute for medical consultation with your healthcare provider. We do not recommend or endorse any specific study and you are advised to discuss the information shown with your healthcare provider. While we believe the information presented on this website to be accurate at the time of writing, we do not guarantee that its contents are correct, complete, or applicable to any particular individual situation. We strongly encourage individuals to seek out appropriate medical advice and treatment from their physicians. We cannot guarantee the availability of any clinical trial listed and will not be responsible if you are considered ineligible to participate in a given clinical trial. We are also not liable for any injury arising as a result of participation. For a full description of terms please refer to our Terms, Conditions & Privacy.